AllianceBernstein
PDSB icon

AllianceBernstein’s PDS Biotechnology PDSB Stock Holding History

AllianceBernstein’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-37,840
Closed -$150K – 3280
2024
Q1 		$150K Hold
37,840
– – ﹤0.01% 2975
2023
Q4 		$188K Hold
37,840
– – ﹤0.01% 2991
2023
Q3 		$191K Hold
37,840
– – ﹤0.01% 2978
2023
Q2 		$190K Buy
+37,840
New +$248K ﹤0.01% 2993
2017
Q4 		– Sell
-1,560
Closed -$335K – 3068
2017
Q3 		$335K Buy
+1,560
New +$323K ﹤0.01% 2725

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein's PDSB Position: Q2 2024 in Review

AllianceBernstein sold out of PDS Biotechnology (PDSB) in Q2 2024, closing a stake of 37,840 shares — an estimated $150K sold.

AllianceBernstein first reported a position in PDSB in Q3 2017 and held it in 5 quarters. The position peaked at $335K in Q3 2017. 77 funds tracked by Wall St. Rank hold PDSB as of Q2 2024.

  • AllianceBernstein reported no remaining PDS Biotechnology position as of Q2 2024 after selling out during the quarter.
  • AllianceBernstein sold 37,840 PDS Biotechnology shares in Q2 2024, an estimated $150K.
  • AllianceBernstein first reported a position in PDS Biotechnology in Q3 2017 and held it in 5 quarters.
  • AllianceBernstein's PDS Biotechnology position peaked at $335K in Q3 2017.
  • 77 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2024.

Based on AllianceBernstein's 13F filing for Q2 2024, filed 14 Aug 2024.